Visceral adiposity, C-peptide levels, and low lipase activities predict HIV-dyslipidemia. (Q51535624)

6 April 2018

title

Visceral adiposity, C-peptide levels, and low lipase activities predict HIV-dyslipidemia. (English)

1 reference

6 April 2018

1 reference

Kevin E Yarasheski

1

1 reference

6 April 2018

Pablo Tebas

2

1 reference

6 April 2018

Sherry Claxton

3

1 reference

6 April 2018

Donna Marin

4

1 reference

6 April 2018

Trey Coleman

5

1 reference

6 April 2018

William G Powderly

6

1 reference

6 April 2018

Clay F Semenkovich

7

1 reference

6 April 2018

publication date

1 July 2003

1 reference

6 April 2018

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

6 April 2018

volume

285

1 reference

6 April 2018

issue

4

1 reference

6 April 2018

page(s)

E899-905

1 reference

6 April 2018

Low lipolytic enzyme activity in patients with severe hypertriglyceridemia on highly active antiretroviral therapy

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

Hepatic lipase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

Metabolic disturbances and wasting in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

Adverse metabolic consequences of HIV protease inhibitor therapy: the search for a central mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

Dyslipidemia due to retroviral protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

The HIV protease inhibitor saquinavir impairs lipid metabolism and glucose transport in cultured adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

Alterations in lipid kinetics in men with HIV-dyslipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

Exercise induces human lipoprotein lipase gene expression in skeletal muscle but not adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

Inhibition of adipocyte differentiation by HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00036.2003

10.1152/AJPENDO.00036.2003

21 January 2018

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

12837664

1 reference

6 April 2018